Cell-Free DNA Isolation and Extraction Market - A Global and Regional Analysis: Focus on Product, Platform, Techniques, Application, End User, and Region - Analysis and Forecast, 2025-2035

Inclusion and Exclusion

1.1 Market Definition
1.2 Early Discovery and Application of cfDNA
1.3 Properties of cfDNA
1.4 Biological Role of cfDNA
1.5 Extraction of Circulating cfDNA
1.6 Application of Circulating cfDNA
1.7 Market Footprint and Growth Potential
1.8 Interruption in Research and Clinical Development and Commercial Operation
1.8.1 Research and Clinical Development
1.8.2 Commercial Operation
1.8.3 Navigating Crisis Recovery and Looking to the Future

2.1 Overview
2.2 Legal Requirements and Framework in the U.S.
2.2.1 FDA Regulation
2.4 Legal Requirements and Framework in Asia-Pacific
2.4.1 China
2.4.2 Japan

3.1 Overview
3.2 Impact Analysis
3.3 Market Drivers
3.4 Market Restraints
3.5 Market Opportunities

4.1 Overview
4.2 Product Launch and Upgradations
4.3 Product Approvals and Business Funding
4.4 Synergistic Activities
4.5 Mergers and Acquisitions
4.6 Market Share Analysis (by Company), 2023 and 2024
4.7 Growth Share Analysis (by Company)

5.1 Overview
5.2 Cell-Free DNA Isolation and Extraction Kits
5.3 Cell-Free DNA Isolation and Extraction Tubes
5.4 Other Consumables

6.1 Overview
6.2 Next-Generation Sequencing (NGS)
6.3 Polymerase Chain Reaction (PCR)
6.4 Real-Time Polymerase Chain Reaction (RT-PCR)
6.5 Digital Polymerase Chain Reaction (dPCR)
6.6 Other Platforms

7.1 Overview
7.2 Magnetic Beads-Based
7.3 Spin Column-Based
7.4 Other Techniques

8.1 Overview
8.2 Non-Invasive Prenatal Testing (NIPT)
8.3 Oncology
8.3.1 Solid Tumor
8.3.2 Hematological Malignancies
8.4 Transplant Rejection
8.5 Other Applications

9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.3 Academic Research Institutes and Laboratories
9.4 Contract Research Organizations (CROs)
9.5 Clinical Diagnostic Centers
9.6 Other End Users

10.1 Overview
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Denmark
10.3.7 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Australia
10.4.6 Singapore
10.4.7 Rest-of-Asia-Pacific (RoAPAC)
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest-of-Latin America (RoLA)
10.6 Rest-of-the-World

11.1 Thermo Fisher Scientific Inc.
11.1.1 Company Overview
11.1.2 Product Portfolio
11.1.3 Target Customers/End Users
11.1.4 Analyst View
11.2 QIAGEN
11.2.1 Company Overview
11.2.2 Product Portfolio
11.2.3 Target Customers/End Users
11.2.4 Analyst View
11.3 Danaher Corporation
11.3.1 Company Overview
11.3.2 Product Portfolio
11.3.3 Target Customers/End Users
11.3.4 Analyst View
11.4 PerkinElmer, Inc.
11.4.1 Company Overview
11.4.2 Product Portfolio
11.4.3 Target Customers/End Users
11.4.4 Analyst View
11.5 Endress+Hauser AG
11.5.1 Company Overview
11.5.2 Product Portfolio
11.5.3 Target Customers/End Users
11.5.4 Analyst View
11.6 Agilent Technologies, Inc.
11.6.1 Company Overview
11.6.2 Product Portfolio
11.6.3 Target Customers/End Users
11.6.4 Analyst View
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 Company Overview
11.7.2 Product Portfolio
11.7.3 Target Customers/End Users
11.7.4 Analyst View
11.8 Merck KGaA
11.8.1 Company Overview
11.8.2 Product Portfolio
11.8.3 Target Customers/End Users
11.8.4 Analyst View
11.9 llumina, Inc.
11.9.1 Company Overview
11.9.2 Product Portfolio
11.9.3 Target Customers/End Users
11.9.4 Analyst View
11.10 Takara Bio Inc.
11.10.1 Company Overview
11.10.2 Product Portfolio
11.10.3 Target Customers/End Users
11.10.4 Analyst View
11.11 Aline Biosciences
11.11.1 Company Overview
11.11.2 Product Portfolio
11.11.3 Target Customers/End Users
11.11.4 Analyst View
11.12 EpiGentek Group, Inc.
11.12.1 Company Overview
11.12.2 Product Portfolio
11.12.3 Target Customers/End Users
11.12.4 Analyst View
11.13 Omega Bio-tek, Inc.
11.13.1 Company Overview
11.13.2 Product Portfolio
11.13.3 Target Customers/End Users
11.13.4 Analyst View
11.14 Promega Corporation
11.14.1 Company Overview
11.14.2 Product Portfolio
11.14.3 Target Customers/End Users
11.14.4 Analyst View
11.15 Streck, Inc.
11.15.1 Company Overview
11.15.2 Product Portfolio
11.15.3 Target Customers/End Users
11.15.4 Analyst View
11.16 AccuBioMed Co., Ltd.
11.16.1 Company Overview
11.16.2 Product Portfolio
11.16.3 Target Customers/End Users
11.16.4 Analyst View
11.17 AMSBIO
11.17.1 Company Overview
11.17.2 Product Portfolio
11.17.3 Target Customers/End Users
11.17.4 Analyst View
11.18 Covaris, Inc.
11.18.1 Company Overview
11.18.2 Product Portfolio
11.18.3 Target Customers/End Users
11.18.4 Analyst View
11.19 EntroGen, Inc.
11.19.1 Company Overview
11.19.2 Product Portfolio
11.19.3 Target Customers/End Users
11.19.4 Analyst View
11.20 NeoGeneStar LLC
11.20.1 Company Overview
11.20.2 Product Portfolio
11.20.3 Target Customers/End Users
11.20.4 Analyst View
11.21 Norgen Biotek Corporation
11.21.1 Company Overview
11.21.2 Product Portfolio
11.21.3 Target Customers/End Users
11.21.4 Analyst View
11.22 STRATEC SE
11.22.1 Company Overview
11.22.2 Product Portfolio
11.22.3 Target Customers/End Users
11.22.4 Analyst View
11.23 System Biosciences, LLC
11.23.1 Company Overview
11.23.2 Product Portfolio
11.23.3 Target Customers/End Users
11.23.4 Analyst View

Figure: Global Cell-Free DNA Isolation and Extraction Market, Dynamics Impact Analysis
Figure: Global Cell-Free DNA Isolation and Extraction Market Coverage
Figure: Global Cell-Free DNA Isolation and Extraction Market, Patent Analysis, January 2022-March 2025
Figure: Global Cell-Free DNA Isolation and Extraction Market, Competitive Landscape, January 2022-March 2025

Table: Global Cell-Free DNA Isolation and Extraction Market Dynamics, Impact Analysis
Table: Global Cell-Free DNA Isolation and Extraction Market (by Product), $Million, 2023-2035
Table: Global Cell-Free DNA Isolation and Extraction Market (by Platform), $Million, 2023-2035
Table: Global Cell-Free DNA Isolation and Extraction Market (by Techniques), $Million, 2023-2035
Table: Global Cell-Free DNA Isolation and Extraction Market (by Application), $Million, 2023-2035
Table: Global Cell-Free DNA Isolation and Extraction Market (End User), $Million, 2023-2035
Table: Global Cell-Free DNA Isolation and Extraction Market (Region), $Million, 2023-2035